Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger SWIM domain-containing protein 8 (ZSWIM8) is a substrate recognition component of a **Cullin-RING E3 ubiquitin ligase complex** that promotes **target-directed microRNA degradation (TDMD)**, a post-transcriptional gene-silencing regulatory process. ZSWIM8 binds Argonaute (AGO) proteins loaded with specific microRNAs extensively paired to targets, enabling ubiquitination and proteasomal degradation of AGO, which then exposes the microRNA for degradation[1][5][4][2]. ZSWIM8 also recognizes misfolded proteins such as ROBO3 and DAB1 for quality control during neural development, and is implicated in axon guidance, embryonic tissue development, and myogenic differentiation[1][3][4]. It contains a characteristic zinc finger SWIM domain, Cul2/VHL boxes, and is evolutionarily conserved from invertebrates to vertebrates[1][2]. No drugs currently target this protein, and it is not classified as a direct therapeutic target, but its biological roles are critical in normal development and disease pathogenesis.
Not applicable/no known drugs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger SWIM domain-containing protein 8 (ZSWIM8).